15-90638618-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022769.5(CRTC3):c.1439A>T(p.Gln480Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022769.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRTC3 | NM_022769.5 | c.1439A>T | p.Gln480Leu | missense_variant | 12/15 | ENST00000268184.11 | NP_073606.3 | |
CRTC3-AS1 | NR_120372.1 | n.509+2424T>A | intron_variant, non_coding_transcript_variant | |||||
CRTC3 | NM_001042574.3 | c.1439A>T | p.Gln480Leu | missense_variant | 12/15 | NP_001036039.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRTC3 | ENST00000268184.11 | c.1439A>T | p.Gln480Leu | missense_variant | 12/15 | 1 | NM_022769.5 | ENSP00000268184 | P3 | |
CRTC3-AS1 | ENST00000559531.1 | n.510+2424T>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250832Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135634
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461210Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 726984
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.1439A>T (p.Q480L) alteration is located in exon 12 (coding exon 12) of the CRTC3 gene. This alteration results from a A to T substitution at nucleotide position 1439, causing the glutamine (Q) at amino acid position 480 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at